(BLUE) stock downgraded by Bank of America and J.P. Morgan after the company's Q3 2024 results. Read more here.

In a recent interview, J.P. Morgan CEO Jamie Dimon expressed growing concerns about what’s happening in the world today, ...

As more wealthy empty nesters stick to the North Shore rather than move to the Loop, the banking giant says they're looking ...

In celebration of its 100th year as an institution open to the public, the Morgan Library and Museum has launched the ...

JAMESTOWN, Pennsylvania (MyValleyTributes) – James Paul “JP” Morgan of Jamestown, passed away peacefully Thursday afternoon, ...

JP Morgan has recently reduced bluebird bio Inc (BLUE) stock to Neutral rating, as announced on August 15, 2024, according to Finviz. Earlier, on December 11, 2023, HSBC Securities had reduced the ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) yesterday and set a price ...

The insurance company tabbed Morgan Stanley veteran Jacques Chappuis to succeed David Hunt at the helm of the Prudential’s $1 ...

National Pension Service raised its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 4.2% ...

Research and development expenses were $15.4 million for the quarter ended September 30, 2024, compared to $7.8 million for the same period in 2023. The increase of $7.6 million was primarily driven ...

A New York exhibition pays homage to a Black woman who passed as white and assembled the financier’s private collection ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...